What is (are) the environmental exposure(s) causing sarcoidosis and influencing diverse clinical phenotypes? |
Studies to identify environmental exposures that are associated with extreme disease phenotypes |
What are the immune mechanisms, including incompletely understood local innate and adaptive immune responses, that could be targeted to more effectively treat sarcoidosis? |
Support efforts to develop relevant animal and in vitro disease models |
Support hypothesis-driven research to identify molecular mechanisms and potential therapeutic targets |
What is the genetic basis of severe sarcoidosis phenotypes? |
Leverage high-throughput, low-cost genome-wide technology |
Genome-wide association studies |
Gene sequencing |
Epigenetics |
How does the host microbiome influence the risk for sarcoidosis or severe sarcoidosis phenotypes? |
Support studies to comprehensively evaluate the microbiome of the lungs and gastrointestinal tract and correlate with clinical and immunological sarcoidosis phenotypes |
What are the molecular pathways and biomarkers that contribute to chronic multisystem sarcoidosis, and how can this information contribute to improved care? |
Conduct longitudinal studies to assess various candidate biomarkers that would serve to assist in establishing the diagnosis, prognosis, and response to treatment |
How do we account for the complex interactions of multiple environmental and host factors as they relate to the phenotypic variability of sarcoidosis? |
Bioinformatic analysis of comprehensive data sets derived from large patient cohorts followed longitudinally |